Boniva (Genentech, Inc.)
Welcome to the PulseAid listing for the Boniva drug offered from Genentech, Inc.. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Genentech, Inc. |
NON-PROPRIETARY NAME: | ibandronate sodium |
SUBSTANCE NAME: | IBANDRONATE SODIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2011-06-01 |
END MARKETING DATE: | 0000-00-00 |
Boniva HUMAN PRESCRIPTION DRUG Details:
Item Description | Boniva from Genentech, Inc. |
LABELER NAME: | Genentech, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3(mg/3mL) |
START MARKETING DATE: | 2011-06-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0004-0191_2fbd353f-ae14-484d-a84b-d5b0e34173f3 |
PRODUCT NDC: | 0004-0191 |
APPLICATION NUMBER: | NDA021858 |
Other IBANDRONATE SODIUM Pharmaceutical Manufacturers / Labelers: